Intimation of Schedule of Analyst/Institutional Investor Meeting

Sun Pharmaceutical Industries Limited SUN HOUSE, Plot No. 201 B/1, Western Express Highway, Goregaon (E), Mumbai 400063, India Tel.: (91-22) 4324 4324 Fax.: (91-22) 4324 4343 Website: www.sunpharma.com Email: secretarial@sunpharma.com CIN: L24230GJ1993PLC019050 03 September 2026 National Stock Exchange of India Limited BSE Limited Scrip Symbol: SUNPHARMA Scrip Code: 524715 Subject - Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 – Intimation of Schedule of Analyst/Institutional Investor Meeting Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the schedule of upcoming analyst/Institutional Investor meeting is as follows: Date Analyst/Investor/Event Venue Type of (Group / One-on-one) Meeting 10-Sept-26 UBS India Summit 2026 Mumbai Physical Group & One-on-one 16-Sept-26 Jefferies India Forum 2026 Delhi Physical Group & One-on-one 17-Sept-26 Kotak Institutional Equities Healthcare Mumbai Physical Group & One-on-one Forum 2026 21-Sept-26 J.P. Morgan India Conference 2026 Mumbai Physical Group & One-on-one 22-Sept-26 Anand Rathi Annual Flagship Conference Mumbai Physical Group & One-on-one G-200 Summit 2026 The company will not be disclosing any Unpublished Price Sensitive Information (UPSI) at these meetings. The schedule of the above-mentioned meetings is subject to change, and the change may occur due to exigencies on either side. For Sun Pharmaceutical Industries Limited (Anoop Deshpande) Company Secretary and Compliance Officer ICSI Membership No.: A23983 Registered Office: SPARC, Tandalja, Vadodara – 390 012, Gujarat, INDIA Reaching People. Touching Lives